Caco-2 cell permeability assays to measure drug absorption

Caco-2 cells are a human colon epithelial cancer cell line used as a model of human intestinal absorption of drugs and other compounds. When cultured as a monolayer, Caco-2 cells differentiate to form tight junctions between cells to serve as a model of paracellular movement of compounds across the monolayer. In addition, Caco-2 cells express transporter proteins, efflux proteins, and Phase II conjugation enzymes to model a variety of transcellular pathways as well as metabolic transformation of test substances. In many respects, the Caco-2 cell monolayer mimics the human intestinal epithelium. One of the functional differences between normal cells and Caco-2 cells is the lack of expression of the cytochrome P450 isozymes and in particular, CYP3A4, which is normally expressed at high levels in the intestine. However, Caco-2 cells may be induced to express higher levels of CYP3A4 by treatment with vitamin D3. Caco-2 cell monolayers are usually cultured on semipermeable plastic supports that may be fitted into the wells of multi-well culture plates. Test compounds are then added to either the apical or basolateral sides of the monolayer. After incubation for various lengths of time, aliquots of the buffer in opposite chambers are removed for the determination of the concentration of test compounds and the computation of the rates of permeability for each compound (called the apparent permeability coefficients). Although radiolabelled compounds were used in the original Caco-2 cells monolayer assays, radiolabelled compounds have been replaced in most laboratories by the use of liquid chromatography-mass spectrometry (LC-MS) and LC-tandem mass spectrometry (LC-MS-MS). Mass spectrometry not only eliminates the need for radiolabelled compounds, but permits the simultaneous measurement of multiple compounds. The measurement of multiple compounds per assay reduces the number of incubations that need to be carried out, thereby increasing the throughput of the experiments. Furthermore, LC-MS and LC-MS-MS add another dimension to Caco-2 assays by facilitating the investigation of the metabolism of compounds by Caco-2 cells.

[1]  D. Ritchie,et al.  The new pre-preclinical paradigm: compound optimization in early and late phase drug discovery. , 2001, Current topics in medicinal chemistry.

[2]  Shiyin Yee,et al.  In Vitro Permeability Across Caco-2 Cells (Colonic) Can Predict In Vivo (Small Intestinal) Absorption in Man—Fact or Myth , 1997, Pharmaceutical Research.

[3]  K. Audus,et al.  The Use of Cultured Epithelial and Endothelial Cells for Drug Transport and Metabolism Studies , 1990, Pharmaceutical Research.

[4]  K. Luthman,et al.  Caco-2 monolayers in experimental and theoretical predictions of drug transport. , 2001, Advanced drug delivery reviews.

[5]  P. Artursson,et al.  Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells. , 1990, Journal of pharmaceutical sciences.

[6]  K Gubernator,et al.  Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes. , 1998, Journal of medicinal chemistry.

[7]  W. Niessen,et al.  Progress in liquid chromatography-mass spectrometry instrumentation and its impact on high-throughput screening. , 2003, Journal of chromatography. A.

[8]  J. Pezzuto,et al.  Human, Rat, and Mouse Metabolism of Resveratrol , 2002, Pharmaceutical Research.

[9]  S. Stavchansky,et al.  Quantitative determination of saquinavir from Caco-2 cell monolayers by HPLC-UV. High performance liquid chromatography. , 2003, Biomedical chromatography : BMC.

[10]  S. Bhattacharyya Combinatorial approaches in anticancer drug discovery: recent advances in design and synthesis. , 2001, Current medicinal chemistry.

[11]  J. Pang,et al.  Determination of in vitro permeability of drug candidates through a caco-2 cell monolayer by liquid chromatography/tandem mass spectrometry. , 2000, Journal of mass spectrometry : JMS.

[12]  D. Shen,et al.  Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism. , 1997, The Journal of pharmacology and experimental therapeutics.

[13]  T. Walle,et al.  Transport of the flavonoid chrysin and its conjugated metabolites by the human intestinal cell line Caco-2. , 1999, Biochemical pharmacology.

[14]  B. Aungst,et al.  The Influence of Donor and Reservoir Additives on Caco-2 Permeability and Secretory Transport of HIV Protease Inhibitors and Other Lipophilic Compounds , 2000, Pharmaceutical Research.

[15]  R. Micetich,et al.  High-throughput caco-2 cell permeability screening by cassette dosing and sample pooling approaches using direct injection/on-line guard cartridge extraction/tandem mass spectrometry. , 2000, Rapid communications in mass spectrometry : RCM.

[16]  P. Augustijns,et al.  Use of Caco-2 cells and LC/MS/MS to screen a peptide combinatorial library for permeable structures. , 1999, International journal of pharmaceutics.

[17]  Y. Berger,et al.  The human intestinal epithelial cell line Caco-2; pharmacological and pharmacokinetic applications , 1995, Cell Biology and Toxicology.

[18]  S. Nylander,et al.  Jejunal Permeability: A Comparison Between the Ussing Chamber Technique and the Single-Pass Perfusion in Humans , 1997, Pharmaceutical Research.

[19]  J. Pappenheimer,et al.  Structural basis for physiological regulation of paracellular pathways in intestinal epithelia , 2005, The Journal of Membrane Biology.

[20]  M. A. Moseley,et al.  CYP3A-like cytochrome P450-mediated metabolism and polarized efflux of cyclosporin A in Caco-2 cells. , 1996, Drug metabolism and disposition: the biological fate of chemicals.

[21]  V. Lee Membrane transporters. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[22]  W. Kramer,et al.  Interaction of renin inhibitors with the intestinal uptake system for oligopeptides and beta-lactam antibiotics. , 1990, Biochimica et biophysica acta.

[23]  I. Hidalgo,et al.  Substrate specificity and some properties of phenol sulfotransferase from human intestinal Caco-2 cells. , 1991, Life sciences.

[24]  M. Yazdanian,et al.  Evaluation of an accelerated Caco-2 cell permeability model. , 2000, Journal of pharmaceutical sciences.

[25]  P. Langguth,et al.  Compound mixtures in Caco-2 cell permeability screens as a means to increase screening capacity. , 2001, Die Pharmazie.

[26]  G. Amidon,et al.  Utilization of peptide carrier system to improve intestinal absorption: targeting prolidase as a prodrug-converting enzyme. , 1992, Journal of pharmaceutical sciences.

[27]  H H USSING,et al.  Active transport of sodium as the source of electric current in the short-circuited isolated frog skin. , 1951, Acta physiologica Scandinavica.

[28]  Kristina Luthman,et al.  Caco-2 monolayers in experimental and theoretical predictions of drug transport1PII of original article: S0169-409X(96)00415-2. The article was originally published in Advanced Drug Delivery Reviews 22 (1996) 67–84.1 , 2001 .

[29]  J. Kolars,et al.  CYP3A gene expression in human gut epithelium. , 1994, Pharmacogenetics.

[30]  I. Hidalgo,et al.  Assessing the absorption of new pharmaceuticals. , 2001, Current topics in medicinal chemistry.

[31]  Claude Roques,et al.  Correlation Between Oral Drug Absorption in Humans, and Apparent Drug Permeability in TC-7 Cells, A Human Epithelial Intestinal Cell Line: Comparison with the Parental Caco-2 Cell Line , 1998, Pharmaceutical Research.

[32]  I. Pastan,et al.  Biochemistry of multidrug resistance mediated by the multidrug transporter. , 1993, Annual review of biochemistry.

[33]  S. Yamashita,et al.  Investigations of influx and accumulation processes of beta-lactam antibiotics and their role in the transmural transfer across rat jejunum. , 1986, Journal of pharmacobio-dynamics.

[34]  P. Artursson,et al.  Epithelial transport of drugs in cell culture. II: Effect of extracellular calcium concentration on the paracellular transport of drugs of different lipophilicities across monolayers of intestinal epithelial (Caco-2) cells. , 1990, Journal of pharmaceutical sciences.

[35]  Huimin Lin,et al.  Metabolism of Flavonoids via Enteric Recycling: Mechanistic Studies of Disposition of Apigenin in the Caco-2 Cell Culture Model , 2003, Journal of Pharmacology and Experimental Therapeutics.

[36]  J. Robinson,et al.  Transport of human growth hormone across Caco-2 cells with novel delivery agents: evidence for P-glycoprotein involvement. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[37]  R. Mckinnon,et al.  Characterisation of CYP3A gene subfamily expression in human gastrointestinal tissues. , 1995, Gut.

[38]  R A Morrison,et al.  Current methodologies used for evaluation of intestinal permeability and absorption. , 2000, Journal of pharmacological and toxicological methods.

[39]  P. Watkins,et al.  Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man. , 1987, The Journal of clinical investigation.

[40]  Akira Tsuji,et al.  Carrier-Mediated Intestinal Transport of Drugs , 1996, Pharmaceutical Research.

[41]  R. Borchardt,et al.  Metabolism of L-alpha-methyldopa in cultured human intestinal epithelial (Caco-2) cell monolayers. Comparison with metabolism in vivo. , 1994, Drug metabolism and disposition: the biological fate of chemicals.

[42]  C E Hop,et al.  Integrating qualitative and quantitative liquid chromatography/tandem mass spectrometric analysis to support drug discovery. , 1999, Rapid communications in mass spectrometry : RCM.

[43]  H. Ussing,et al.  Active transport of sodium as the source of electric current in the short-circuited isolated frog skin. Reprinted from Acta. Physiol. Scand. 23: 110-127, 1951. , 1999, Journal of the American Society of Nephrology : JASN.

[44]  Young Geun Shin,et al.  Increasing the throughput and productivity of Caco-2 cell permeability assays using liquid chromatography-mass spectrometry: application to resveratrol absorption and metabolism. , 2003, Combinatorial chemistry & high throughput screening.

[45]  D K Yu,et al.  The Contribution of P‐glycoprotein to Pharmacokinetic Drug‐Drug Interactions , 1999, Journal of clinical pharmacology.

[46]  M. Humphrey,et al.  Peptides and related drugs: a review of their absorption, metabolism, and excretion. , 1986, Drug metabolism reviews.

[47]  W. Peters,et al.  Cytochromes P-450 in the intestinal mucosa of man. , 1989, Biochemical pharmacology.

[48]  Risto Kostiainen,et al.  N-in-One Permeability Studies of Heterogeneous Sets of Compounds Across Caco-2 Cell Monolayers , 2003, Pharmaceutical Research.

[49]  P. Watkins,et al.  Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1alpha,25-dihydroxyvitamin D3. , 1997, Molecular pharmacology.

[50]  M. Rousset,et al.  Intestinal responses to xenobiotics. , 2001, Toxicology in vitro : an international journal published in association with BIBRA.

[51]  P. Artursson,et al.  Transport and permeability properties of human Caco-2 cells: An in vitro model of the intestinal epithelial cell barrier , 1990 .

[52]  T. Walle,et al.  Transport and Metabolism of the Tea Flavonoid (–)-Epicatechin by the Human Intestinal Cell Line Caco-2 , 2001, Pharmaceutical Research.

[53]  S. L. Clark The Ingestion of Proteins and Colloidal Materials by Columnar Absorptive Cells of the Small Intestine in Suckling Rats and Mice , 1959, The Journal of biophysical and biochemical cytology.

[54]  P. Watkins,et al.  First-pass midazolam metabolism catalyzed by 1alpha,25-dihydroxy vitamin D3-modified Caco-2 cell monolayers. , 1999, The Journal of pharmacology and experimental therapeutics.

[55]  J. Hochman,et al.  Comparative studies of drug-metabolizing enzymes in dog, monkey, and human small intestines, and in Caco-2 cells. , 1996, Drug metabolism and disposition: the biological fate of chemicals.

[56]  R. Conradi,et al.  Caco-2 Cell Monolayers as a Model for Drug Transport Across the Intestinal Mucosa , 1990, Pharmaceutical Research.

[57]  T. Tsuruo,et al.  Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells. Kinetics of vinblastine secretion and interaction with modulators. , 1993, The Journal of biological chemistry.

[58]  R. Morrison,et al.  Higher-throughput screening for Caco-2 permeability utilizing a multiple sprayer liquid chromatography/tandem mass spectrometry system. , 2003, Rapid communications in mass spectrometry : RCM.

[59]  Edward B. Roche,et al.  Design of biopharmaceutical properties through prodrugs and analogs , 1977 .

[60]  Thomas J. Raub,et al.  Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. , 1989, Gastroenterology.

[61]  L. Romanyshyn,et al.  Bioanalytical applications of 'fast chromatography' to high-throughput liquid chromatography/tandem mass spectrometric quantitation. , 2000, Rapid communications in mass spectrometry : RCM.

[62]  P. Artursson,et al.  Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. , 1991, Biochemical and biophysical research communications.

[63]  H Lennernäs,et al.  Human intestinal permeability. , 1998, Journal of pharmaceutical sciences.

[64]  P. Galletti,et al.  Transport mechanism and metabolism of olive oil hydroxytyrosol in Caco‐2 cells , 2000, FEBS letters.

[65]  P. Beaune,et al.  Cytochrome P 450 isoenzymes, epoxide hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissues. , 1990, The Journal of pharmacology and experimental therapeutics.

[66]  Richard A. Morrison,et al.  Evaluation of Biocoat® Intestinal Epithelium Differentiation Environment (3-Day Cultured Caco-2 Cells) as an Absorption Screening Model with Improved Productivity , 1997, Pharmaceutical Research.

[67]  G. Caldwell,et al.  In vitro permeability of eight beta-blockers through Caco-2 monolayers utilizing liquid chromatography/electrospray ionization mass spectrometry. , 1998, Journal of mass spectrometry : JMS.

[68]  M Rowland,et al.  Kinetic profiling of P-glycoprotein-mediated drug efflux in rat and human intestinal epithelia. , 2001, The Journal of pharmacology and experimental therapeutics.

[69]  G Mannens,et al.  Strategies for absorption screening in drug discovery and development. , 2001, Current topics in medicinal chemistry.

[70]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.